These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26408533)

  • 1. Self-Reported And Objectively Recorded Colorectal Cancer Screening Participation In England.
    Lo SH; Waller J; Vrinten C; Wardle J; von Wagner C
    J Med Screen; 2016 Mar; 23(1):17-23. PubMed ID: 26408533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme.
    Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
    Gut; 2015 Feb; 64(2):282-91. PubMed ID: 24812001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lack of information engagement among colorectal cancer screening non-attenders: cross-sectional survey.
    Kobayashi LC; Waller J; von Wagner C; Wardle J
    BMC Public Health; 2016 Jul; 16():659. PubMed ID: 27473593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive ability and personality as predictors of participation in a national colorectal cancer screening programme: the English Longitudinal Study of Ageing.
    Gale CR; Deary IJ; Wardle J; Zaninotto P; Batty GD
    J Epidemiol Community Health; 2015 Jun; 69(6):530-5. PubMed ID: 25648994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using physician-linked mailed invitations in an organised colorectal cancer screening programme: effectiveness and factors associated with response.
    Tinmouth J; Baxter NN; Paszat LF; Rabeneck L; Sutradhar R; Yun L
    BMJ Open; 2014 Mar; 4(3):e004494. PubMed ID: 24622950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-perceived Mental Health Status and Uptake of Fecal Occult Blood Test for Colorectal Cancer Screening in Canada: A Cross-Sectional Study.
    Hategekimana C; Karamouzian M
    Int J Health Policy Manag; 2016 Feb; 5(6):365-71. PubMed ID: 27285514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women.
    Blanks RG; Benson VS; Alison R; Brown A; Reeves GK; Beral V; Patnick J; Green J
    Br J Cancer; 2015 Apr; 112(9):1562-7. PubMed ID: 25742470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decomposing socio-economic inequality in colorectal cancer screening uptake in England.
    Solmi F; Von Wagner C; Kobayashi LC; Raine R; Wardle J; Morris S
    Soc Sci Med; 2015 Jun; 134():76-86. PubMed ID: 25917138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer.
    Steele RJ; McClements PL; Libby G; Carey FA; Fraser CG
    Colorectal Dis; 2014 Jan; 16(1):28-32. PubMed ID: 24034143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort.
    He E; Lew JB; Egger S; Banks E; Ward RL; Beral V; Canfell K
    Prev Med; 2018 Jan; 106():185-193. PubMed ID: 29109015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening.
    Steele RJ; Kostourou I; McClements P; Watling C; Libby G; Weller D; Brewster DH; Black R; Carey FA; Fraser C
    BMJ; 2010 Oct; 341():c5531. PubMed ID: 20980376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
    Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
    Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of repeat participation in the NHS bowel cancer screening programme.
    Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
    Br J Cancer; 2015 Jan; 112(1):199-206. PubMed ID: 25429524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial.
    Smith SG; Wardle J; Atkin W; Raine R; McGregor LM; Vart G; Morris S; Duffy SW; Moss S; Hackshaw A; Halloran S; Kralj-Hans I; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas M; Counsell N; von Wagner C
    BMC Cancer; 2017 Aug; 17(1):543. PubMed ID: 28806955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests.
    Logan RF; Patnick J; Nickerson C; Coleman L; Rutter MD; von Wagner C;
    Gut; 2012 Oct; 61(10):1439-46. PubMed ID: 22156981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro actions in colorectal cancer screening participation: a population-based survey study.
    Lo SH; Waller J; Vrinten C; von Wagner C
    BMC Cancer; 2015 May; 15():438. PubMed ID: 26016989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.